Supply Chain

A congressional oversight subcommittee has opened an investigation into the FDA's regulation of the HeartWare Ventricular Assist Device, which was implanted into thousands of Americans after the agency identified safety issues with the heart pump, ProPublica reported March 23. 

As the Russia-Ukraine war persists, U.S. healthcare systems are already seeing the effects of the conflict through increased prices for oil and natural gas and Ukrainian refugees seeking treatment. 

U.S. Pharmacopeia, an independent scientific organization, released a medicine supply map aiming to build visibility and identify which pharmaceutical ingredients are vulnerable to shortages, the organization said March 16. 

Here are 10 health systems that have posted job listings for supply chain expertise in the last week: 

What's the best distribution strategy for your organization? What are the key considerations when trying to identify the optimal distribution strategy?

The FDA on March 21 shared recommendations for healthcare organizations to conserve prefilled 0.9 percent sodium chloride intravenous lock/flush syringes amid a national shortage. 

The FDA would be allowed to collect at least $1.78 billion in user fees over five years under a reauthorization of the medical device user fee program, according to a series of recommendations from the agency and representatives from the…

To help ease chronic blood shortages in the U.S., hospitals should partner with blood centers to increase donations and work with centers to host blood drives, America's Blood Centers said in a March bulletin. 

States will see a significant reduction in shipments of COVID-19 monoclonal antibody treatments from the federal government beginning March 21 as the White House's request for $15.6 billion in pandemic funding stalls in Congress, ABC News reported. 

The FDA is returning to normal facility inspection operations, which were significantly disrupted by the COVID-19 pandemic, according to a March 21 report from The New York Times.